SCHEMBL1646540

SCHEMBL1646540

COc1cc(/C=C/C(=O)CC(C)=O)ccc1O

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 9/20 0.89
MAPT P10636 7/20 0.89
BACE1 P56817 4/20 0.89
NFKB1 P19838 4/20 0.89
MMP9 P14780 4/20 0.89
CYP2D6 P10635 3/20 0.89
ALOX5 P09917 3/20 0.89
STAT3 P40763 3/20 0.89
NFKB2 Q00653 3/20 0.89
RELA Q04206 3/20 0.89
CYP2C9 P11712 2/20 0.89
TSHR P16473 2/20 0.89
HSD17B10 Q99714 2/20 0.89
ABCB1 P08183 2/20 0.89
AKR1B1 P15121 2/20 0.89
MAOA P21397 2/20 0.89
MAOB P27338 2/20 0.89
HDAC3 O15379 2/20 0.89
HDAC1 Q13547 2/20 0.89
HDAC2 Q92769 2/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29985625 1.00 APP (0.89) APPMAPTBACE1NFKB1MMP9
SCHEMBL29924151 1.00 APP (0.89) APPMAPTBACE1NFKB1MMP9
SCHEMBL1646542 1.00 APP (0.89) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL2177792 0.94 APP (0.94) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL20562725 0.94 APP (0.94) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL40025 0.94 APP (0.94) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL2177794 0.94 APP (0.94) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL17629819 0.94 APP (1.00) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL8440 0.94 APP (1.00) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL8336603 0.94 APP (1.00) APPMAPTBACE1NFKB1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1901618-B1 HYDROXYPHENYLALKADIONES AND THEIR USE FOR MASKING BITTER TASTE AND/OR FOR INTENSIFYING SWEET TASTE SYMRISE GMBH & CO KG (DE) 2009-06-17 EP claimed
US-20080227866-A1 Hydroxyphenylalkadiones and Their Use for Masking Bitter Taste and/or for Intensifying Sweet Taste SYMRISE GMBH & CO. KG (DE) 2008-09-18 US claimed
WO-2022214995-A1 PROBE DIRECTED TO ENZYME ALDH1A3 AND USE THEREOF IN THE DIAGNOSIS OF GLIOBLASTOMA UNIVERSITA' DEGLI STUDI DEL PIEMONTE ORIENTALE "A. AVOGADRO" (IT) 2022-10-13 WO disclosed
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
US-8552220-B2 Therapeutic agent for Alzheimer's disease TOKYO INSTITUTE OF TECHNOLOGY (JP) 2013-10-08 US disclosed
US-20110111068-A1 Inhibitors of cognitive decline CALIFORNIA STATE UNIVERSITY CHANNEL ISLANDS FOUNDATION, CHANNEL ISLANDS ALZHEIMER'S INSTITUTE 2011-05-12 US disclosed
EP-2305629-A1 THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE Tokyo Institute of Technology (JP) 2011-04-06 EP disclosed
US-7723377-B2 Inhibitors of cognitive decline COGNITION THERAPEUTICS, INC. (US) 2010-05-25 US disclosed
US-7723377-B2 Inhibitors of cognitive decline COGNITION THERAPEUTICS, INC. (US) 2010-05-25 US disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 EP disclosed
EP-1901618-B1 HYDROXYPHENYLALKADIONES AND THEIR USE FOR MASKING BITTER TASTE AND/OR FOR INTENSIFYING SWEET TASTE SYMRISE GMBH & CO KG (DE) 2009-06-17 EP disclosed
US-20080227866-A1 Hydroxyphenylalkadiones and Their Use for Masking Bitter Taste and/or for Intensifying Sweet Taste SYMRISE GMBH & CO. KG (DE) 2008-09-18 US disclosed
US-20080227866-A1 Hydroxyphenylalkadiones and Their Use for Masking Bitter Taste and/or for Intensifying Sweet Taste SYMRISE GMBH & CO. KG (DE) 2008-09-18 US disclosed
US-20080227866-A1 Hydroxyphenylalkadiones and Their Use for Masking Bitter Taste and/or for Intensifying Sweet Taste SYMRISE GMBH & CO. KG (DE) 2008-09-18 US disclosed
US-20080193574-A1 Inhibitors Of Cognitive Decline COGNITION THERAPEUTICS, INC. 2008-08-14 US disclosed
US-20080193574-A1 Inhibitors Of Cognitive Decline COGNITION THERAPEUTICS, INC. 2008-08-14 US disclosed
EP-1901618-A1 HYDROXYPHENYLALKADIONES AND THEIR USE FOR MASKING BITTER TASTE AND/OR FOR INTENSIFYING SWEET TASTE Symrise GmbH & Co. KG (DE) 2008-03-26 EP disclosed
WO-2007003527-A1 HYDROXYPHENYLALKADIONES AND THEIR USE FOR MASKING BITTER TASTE AND/OR FOR INTENSIFYING SWEET TASTE SYMRISE GMBH & CO. KG (DE) 2007-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 APP 2/4885MAPT 8/4885BACE1 1/4885
US-20110111068-A1 Inhibitors of cognitive decline NAA50, NOS1, NOS2 APP 51/4885MAPT 71/4885BACE1 7/4885
US-20080227866-A1 Hydroxyphenylalkadiones and Their Use for Masking Bitter Taste and/or for Intensifying Sweet Taste TAS2R1, TAS2R5, TAS2R50 APP 3569/4885MAPT 4869/4885BACE1 2846/4885
US-20080193574-A1 Inhibitors Of Cognitive Decline NAA50, NOS1, NOS2 APP 51/4885MAPT 71/4885BACE1 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.